Orchard Therapeutics - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.
Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 (H1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 (H1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 89 Pages
From
Gene Therapy for Mucopolysaccharidosis - A Pipeline Analysis Report - Product Thumbnail Image

Gene Therapy for Mucopolysaccharidosis - A Pipeline Analysis Report

  • Report
  • 83 Pages
From
Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • 449 Pages
From
Gene Therapy Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Gene Therapy Market (2nd Edition), 2018-2030

  • Report
  • 555 Pages
From
Cell Therapy Manufacturing Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Cell Therapy Manufacturing Market (2nd Edition), 2018-2030

  • Report
  • 444 Pages
From
Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing - Product Thumbnail Image

Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing

  • Report
  • 211 Pages
From
2019 Future of Metachromatic Leukodystrophy (MLD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments - Product Thumbnail Image

2019 Future of Metachromatic Leukodystrophy (MLD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

  • Report
  • 40 Pages
From
Global Gene Therapy Market 2018-2022 - Product Thumbnail Image

Global Gene Therapy Market 2018-2022

  • Report
  • 112 Pages
From
2019 Thalassemia R&D Pipeline Drugs, Companies, Trials and Developments - Product Thumbnail Image

2019 Thalassemia R&D Pipeline Drugs, Companies, Trials and Developments

  • Report
  • 120 Pages
From
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 42 Pages
From
Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth - Product Thumbnail Image

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

  • Report
  • 141 Pages
From
Severe Combined Immune Deficiency (SCID) Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Severe Combined Immune Deficiency (SCID) Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 78 Pages
From
  • 13 Results (Page 1 of 1)
Loading Indicator
adroll